Modeling from the Stop TB Partnership shows that the COVID-19 pandemic is expected to reverse tuberculosis (TB) progress by at least five to eight years. The FHI 360 work featured in this year’s Union World Conference on Lung Health highlights our strategies to identify, prevent and treat TB and other infectious diseases.
Oral abstract session: OA-15 Strategies to find the missing millions Abstract: The Double X strategy: increasing tuberculosis detection in community and facility settings in Vietnam Authors attending: Anh Innes, Hien Mai, Luong Quach |
Oral abstract session: OA-17 Stakeholder interaction in TB care Abstract: Preliminary findings on factors associated with delayed care-seeking among TB patients in the private sector in Indonesia Authors attending: Daniel Sahannggamu, Lisa Stevens, Kharisma Nugroho |
Oral abstract session: OA-26 Challenges for programmatic management of drug-resistant TB Abstract: Interim treatment outcomes of patients with drug-resistant tuberculosis on standard short and long all oral regimens in the Philippines Authors attending: Mary Rosary Santiago, Ruth Chi |
Poster: Sustaining implementation and strengthening active drug safety monitoring and management system for drug-resistant TB in the Philippines amid COVID-19 pandemic Authors attending: Mary Rosary Santiago, Ruth Chi |
Poster: Initiating strategic health purchasing for TB program in Indonesia: a budget impact analysis Authors attending: Sarah Saragih |
Poster: Tele-contact investigation and TB preventive treatment among household contacts of bacteriologically confirmed TB cases in a tertiary hospital in the Philippines amid COVID-19 pandemic Authors attending: Jeremiah Calderon, Pilar Mabasa, Nichel Marquez |
Poster: Impact of the COVID-19 pandemic on TB case detection using GeneXpert, Dhaka, Bangladesh Authors attending: Sharmin Islam |
Poster: Community-based stool specimen collection, storage and transport improves TB diagnosis in children Authors attending: Cuong Duong, Lien Tran |
FHI 360
@FHI 360